HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marie Maynadier Selected Research

Mannose (D-Mannose)

6/2019Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.
1/2019Mannose 6-phosphonate labelling: A key for processing the therapeutic enzyme in Pompe disease.
10/2018Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase.
11/2016Design of Potent Mannose 6-Phosphate Analogues for the Functionalization of Lysosomal Enzymes To Improve the Treatment of Pompe Disease.
2/2016Ruthenium(ii) complex-photosensitized multifunctionalized porous silicon nanoparticles for two-photon near-infrared light responsive imaging and photodynamic cancer therapy.
5/2015Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.
12/2014Two-photon excitation of porphyrin-functionalized porous silicon nanoparticles for photodynamic therapy.
11/2011Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.
12/2010Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marie Maynadier Research Topics

Disease

21Neoplasms (Cancer)
09/2016 - 01/2008
19Breast Neoplasms (Breast Cancer)
03/2019 - 01/2008
3Prostatic Neoplasms (Prostate Cancer)
06/2019 - 05/2015
3Glycogen Storage Disease Type II (Pompe's Disease)
01/2019 - 11/2016
2Neoplasm Metastasis (Metastasis)
11/2013 - 11/2012
1Muscular Diseases (Myopathy)
11/2016
1Retinoblastoma (Glioblastoma, Retinal)
08/2012
1Rare Diseases (Rare Disease)
08/2012
1Colorectal Neoplasms (Colorectal Cancer)
02/2012
1Phototoxic Dermatitis (Phototoxicity)
12/2010
1Obesity
02/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2009

Drug/Important Bio-Agent (IBA)

9Mannose (D-Mannose)IBA
06/2019 - 12/2010
71-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2019 - 12/2010
6Silicon Dioxide (Silica)FDA LinkGeneric
06/2019 - 11/2011
6Pharmaceutical PreparationsIBA
09/2016 - 02/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
09/2016 - 09/2014
3EnzymesIBA
01/2019 - 11/2016
3Estrogen Receptor Modulators (Antiestrogen)IBA
08/2016 - 01/2008
3Estrogen ReceptorsIBA
08/2016 - 01/2008
3SiliconIBA
06/2016 - 05/2013
3pepstatin (pepstatin A)IBA
02/2016 - 10/2013
3CamptothecinIBA
12/2013 - 02/2012
3Estrogens (Estrogen)FDA Link
11/2012 - 01/2008
3Estrogen Receptor alphaIBA
11/2012 - 03/2008
2CationsIBA
06/2019 - 05/2015
2GlucosidasesIBA
10/2018 - 11/2016
2AcidsIBA
10/2018 - 11/2016
2Bortezomib (Velcade)FDA Link
08/2016 - 11/2012
2Proteasome InhibitorsIBA
08/2016 - 11/2012
2LigandsIBA
02/2016 - 03/2008
2Photosensitizing Agents (Photosensitizers)IBA
02/2016 - 02/2012
2JMV4463IBA
02/2016 - 10/2013
2GoldIBA
01/2016 - 01/2015
2PorphyrinsIBA
05/2015 - 05/2013
2Aspartic Acid ProteasesIBA
11/2013 - 10/2013
2Cathepsin DIBA
11/2013 - 10/2013
1Dendrimers (Dendrons)IBA
03/2019
1AT 760IBA
09/2016
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
08/2016
1Fulvestrant (Faslodex)FDA Link
08/2016
1Hydroxyl RadicalIBA
08/2016
1TamoxifenFDA LinkGeneric
08/2016
1mannose-6-phosphateIBA
06/2016
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2016
1RutheniumIBA
02/2016
1statineIBA
02/2016
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
02/2016
1DisulfidesIBA
08/2015
1rhodamine BIBA
07/2015
1LectinsIBA
05/2015
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
05/2015
1Mannose ReceptorIBA
12/2014
1Phosphotransferases (Kinase)IBA
03/2014
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
11/2013
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2013
1Plasminogen Activators (Plasminogen Activator)IBA
11/2013
1Peptide Hydrolases (Proteases)FDA Link
11/2013
1DipeptidesIBA
10/2013
1Fluorouracil (Carac)FDA LinkGeneric
09/2013
1ProdrugsIBA
09/2013
1DesmocollinsIBA
11/2012
1CateninsIBA
11/2012
1Proteins (Proteins, Gene)FDA Link
11/2012
1PlakophilinsIBA
11/2012
1Desmoplakins (Desmoplakin)IBA
11/2012
1Cyclin-Dependent Kinases (cdk Proteins)IBA
11/2012
1CarbohydratesIBA
08/2012
1galactose receptorIBA
02/2012
1Galactose (Galactopyranose)FDA LinkGeneric
02/2012
1AdipokinesIBA
02/2009
1RimonabantIBA
02/2009
1AdiponectinIBA
02/2009
1DNA (Deoxyribonucleic Acid)IBA
03/2008
1Cyclin-Dependent Kinase Inhibitor p21IBA
03/2008

Therapy/Procedure

11Therapeutics
10/2018 - 01/2008
10Photochemotherapy (Photodynamic Therapy)
06/2019 - 11/2011
2Precision Medicine
06/2016 - 05/2015
1Enzyme Therapy
01/2019
1Enzyme Replacement Therapy
10/2018
1Lasers (Laser)
09/2016
1Nanospheres
01/2016